Loading…
Loading…
Henderson, NV and Toronto, ON, March 10, 2025 (GLOBE NEWSWIRE) -- George Sharp, CEO of Forwardly, Inc. (OTCMKT: FORW), provides the following updates to the company’s shareholders. Due to the objections of the United States Securities and Exchange (“SEC”) regarding the company’s S-1 filing under the 1934 Act—the SEC has requested that Forwardly file under the 1940 Act—the company has elected to withdraw its S-1 filing for the time being. This is due to the burden of work and expense required to file under the 1940 Act. Forwardly expects that the circumstances under which the company is required to file under the 1940 Act may change during 2025, after which the company will be able to file under the 1934 Act. aAdsList.push('Article'); aAdsListSize.push([300, 250]); aAdsListCA.push(null); Ligand Innovation Global, with whom Forwardly has partnered in the development of a portable ventilator, reports that its VitaCaeli G1 appears to be poised to be approved by the FDAs of Nigeria and Ghana with immediate large orders of thousands of units to follow. Ligand believes that this could be accomplished during the second quarter of 2025. However, as always, Forwardly cautions investors that the current situation is speculative and that these developments may not occur. Forwardly continues to entertain additional partnerships with legitimate enterprises.About Forwardly, Inc. Forwardly is an opportunity investor seeking to partner in fresh ideas. The company is headed by George Sharp, a longtime whistleblower, advocate against microcap fraud, and defender of shareholder rights. In addition to his continued participation in these activities, Mr. Sharp consults to public companies, attorneys and those associated with the financial markets. He is also a former consultant to OTC Markets Group, Inc. Further information about Forwardly, Inc. can be obtained through its website at www.ForwardlyPlaced.comSafe Harbor Statement This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. You can identify these statements by the use of the words "may," "will," "should," "plans," "expects," "anticipates," "continue," "estimates," "projects," "intends," and similar expressions. Forward-looking statements involve risks and uncertainties that could cause results to differ materially from those projected or anticipated. These risks and uncertainties include, but are not limited to, the Company's ability to successfully execute its expanded business strategy, including by entering into definitive agreements with suppliers, commercial partners and customers; general economic and business conditions, effects of continued geopolitical unrest and regional conflicts, competition, changes in technology and methods of marketing, delays in completing various engineering and manufacturing programs, changes in customer order patterns, changes in product mix, continued success in technical advances and delivering technological innovations, shortages in components, production delays due to performance quality issues with outsourced components, regulatory requirements and the ability to meet them, government agency rules and changes, and various other factors beyond the Company's control. CONTACT:Forwardly, Inc.3535 Executive Terminal DriveSuite 110Henderson, NV 89052702-840-4433 Source: Forwardly, Inc.2025 GlobeNewswire, Inc., source Press Releases
Henderson, NV and Toronto, ON, March 10, 2025 (GLOBE NEWSWIRE) -- George Sharp, CEO of Forwardly, Inc. (OTCMKT: FORW), provides the following updates to the company's shareholders.
ATLANTA--(BUSINESS WIRE)-- #HRinnovation--Forwardly and Southern Company lead growing workplace benefits trend with divorce and relationship support at the forefront.
Henderson, NV, Aug. 01, 2023 (GLOBE NEWSWIRE) -- George Sharp, CEO of Forwardly, Inc. (OTCMKT: FORW), provides the following updates to the company's shareholders.
Mississauga, ON and Henderson, NV, Oct. 13, 2021 (GLOBE NEWSWIRE) -- Dr. Dayo Olakulehin, CEO of Ligand Innovation Global, Inc., (“Ligand”) a partially owned company and partner of Forwardly, Inc. (OTCMKT: FORW), announced today that Ligand has produced two working units of the latest iteration of the LifeAir G1 Portable Ventilator. Upon completion of the production of four additional prototypes, expectedly within the next two weeks, the LifeAir G1 will be fully commissioned.
Are these hot penny stocks on your watchlist right now? The post Hot Penny Stocks To Watch Making Big Moves This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Mississauga, ON and Henderson, NV, Aug. 25, 2021 (GLOBE NEWSWIRE) -- Dr. Dayo Olakulehin, CEO of Ligand Innovation Global, Inc., (“Ligand”) a partially owned company and partner of Forwardly, Inc. (OTCMKT: FORW), announced today that Ligand has received important designations under the Patent Cooperation Treaty (“PCT”).
Mississauga, ON and Henderson, NV, Aug. 04, 2021 (GLOBE NEWSWIRE) -- Dr. Dayo Olakulehin, CEO of Ligand Innovation Global, Inc., (“Ligand”) a partially owned company and partner of Forwardly, Inc. (OTCMKT: FORW), announced today that the Ligand has achieved significant breakthroughs in its development of the latest prototype of the LifeAir G1 portable ventilator.
No recent filings indexed.